Core Laboratories Analyst Price Targets - Benzinga

Core Laboratories Inc

CLBNYSE

Trade with Public

Trade with Public

$11.61

0.161.42%

Ult. Agg.: Sep 17, 1:15 PM

Panoramica Notizie Previsioni utiliObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

Core Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for Core Laboratories (CLB).

Price Target Range — 8 Quarters

Analyst Consensus — 4 Analysts

3Hold

1Sell

Consensus RatingNeutral# Analysts4Avg. Consensus PT$14Upside to Avg. PT+22.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 16, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$13→$12
May 13, 2025	Citigroup	Scott Gruber	PT Cut	Neutral	$16→$13
Apr 15, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$19→$15
Mar 12, 2025	Citigroup	Scott Gruber	Upgrade	Sell→Neutral	$15→$16
Feb 20, 2025	Citigroup	Scott Gruber	PT Raise	Sell	$14→$15
Oct 31, 2024	Citigroup	Scott Gruber	PT Cut	Sell	$15→$14
Jul 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$18→$22
Jul 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$16→$15
Jul 15, 2024	Piper Sandler	Luke Lemoine	PT Cut	Neutral	$18→$17
Apr 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$17→$18
Apr 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$17→$16
Feb 5, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$21→$17
Jan 29, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$23→$21
Sep 18, 2023	Citigroup	Scott Gruber	PT Cut	Sell	$21→$20

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

Benzinga Newsdesk

PRO
Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.

Benzinga Newsdesk